Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “Relapsing Multiple Sclerosis (RMS)”
Approved 1
- UblituximabTG THERAPEUTICS, INC.Relapsing Multiple Sclerosis (RMS)
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.